Search Results
Found 1 results
510(k) Data Aggregation
(109 days)
Sapphire Pro Powder-Free Royal Blue Nitrile Exam Gloves
A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 Standard Practice for Assessment for Medical Gloves to Permeation by Chemotherapy Drugs.
The Sapphire Pro Powder-Free Royal Blue Nitrile Exam Gloves are non-sterile, single use, disposable gloves intended for medical purposes to be worn on the hands of examiners to prevent contamination between a patient and an examiner. The gloves are nitrile, powder-free, ambidextrous, and blue-colored with a beaded cuff. The range of sizes includes small, medium, large, and extra-large.
The provided document is a 510(k) summary for the Sapphire Pro Powder-Free Royal Blue Nitrile Exam Gloves, detailing their substantial equivalence to a predicate device. It includes information on acceptance criteria and performance for various tests relevant to examination gloves, particularly concerning permeation by chemotherapy drugs and fentanyl.
Here's an analysis of the acceptance criteria and the study that proves the device meets them, based solely on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
The document provides a "Summary of Nonclinical Testing" table. This section outlines the tests performed, their purpose, acceptance criteria, and the results for the Sapphire Pro Powder-Free Royal Blue Nitrile Exam Gloves.
Name of Test / Standard | Purpose | Acceptance Criteria | Reported Device Performance (Results) |
---|---|---|---|
ISO 10993-10:2010 (2014) | Irritation | Pass / Fail | Pass – Under the conditions of the study, the subject device is not a primary skin irritant. |
ISO 10993-10:2010 (2014) | Sensitization | Pass / Fail | Pass - Under the conditions of the study, the subject device is not a primary skin sensitizer. |
ISO 10993-5:2009 (2014) | Cytotoxicity | Pass / Fail | Fail – Under the conditions of the study, the subject device is cytotoxic. |
ISO 10993-11:2017 | Acute Systemic Toxicity | Pass / Fail | Pass - Under the conditions of the study, the subject device is not toxic. |
ASTM D6319-19 ASTM D3767-03 (2020) | Physical Dimensions | Length: 220 mm min. | |
Width: 70 mm min. | |||
Thickness – Palm and Finger: 0.05 mm min. | Pass | ||
ASTM D6978-05 (2019) | Permeation of Fentanyl | 240 minutes breakthrough time min. | Pass (>240 minutes breakthrough time for Fentanyl Citrate 100mcg/2ml) |
ASTM D6978-05 (2019) | Permeation of Chemotherapy Drugs | 240 minutes breakthrough time min. | Mixed Results (See breakdown below) |
ASTM D5151-19 | Detection of Holes | Leakage detection, AQL 2.5 | Pass |
ASTM D6124-06 (2017) | Residual Powder | Max 2.0 mg / glove | Pass |
ASTM D6319-19 ASTM D412-16 (2021) ASTM D573-04 (2019) | Physical Properties (Tensile Strength & Elongation) | Tensile Strength: Before Aging ≥ 14 MPa, min; After Aging ≥ 14 MPa, min | |
Elongation: Before Aging 500%, min.; After Aging 400%, min. | Pass |
Detailed Chemotherapy Drug Permeation Results (from "Indications for Use" section):
Chemotherapy Drug and Concentration | Breakthrough Time (minutes) | Acceptance Criteria (from table above) |
---|---|---|
Carmustine (BNCU) (3.3 mg/ml) | 25.5 | 240 |
Doxorubicin HCl (2.0 mg/ml) | >240 | Pass |
Etoposide (20.0 mg/ml) | >240 | Pass |
5-Fluorouracil (50.0 mg/ml) | >240 | Pass |
Methotrexate (25.0 mg/ml) | >240 | Pass |
Paclitaxel (6.0 mg/ml) | >240 | Pass |
Thiotepa (10.0 mg/ml) | 47.7 | 240 |
Note on Cytotoxicity: The device failed the cytotoxicity test ("Fail – Under the conditions of the study, the subject device is cytotoxic."). However, the conclusion states that the device is "as safe, as effective, and performs as well as or better than the legally marketed predicate device." The comparative table indicates the predicate device was also "cytotoxic," suggesting this is an anticipated characteristic for this type of nitrile glove and not a disqualifying factor for substantial equivalence in this context.
2. Sample size used for the test set and the data provenance
The document specifies the tests conducted according to various ASTM and ISO standards for medical gloves. While the standards imply established testing methodologies and sample sizes (e.g., AQL 2.5 for hole detection typically involves specific sample sizes), the exact numerical sample sizes used for each specific test (e.g., for biocompatibility, physical properties, or permeation tests) are not explicitly stated in this summary.
Data provenance: The tests were conducted according to internationally recognized standards (ASTM, ISO). The document does not specify the country of origin of the data collectors or if the data was retrospective or prospective. It is implied to be prospective testing carried out for the device's clearance.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
This section is not applicable to this document. The "ground truth" for medical gloves like these is established through standardized laboratory testing procedures (e.g., ASTM D6978-05 for permeation, ASTM D6319-19 for physical dimensions, ISO 10993 series for biocompatibility). There are no human "experts" establishing a "ground truth" for classification or diagnosis in the way one would for an AI CAD system for medical imaging. The performance is measured against objective, measurable criteria defined by the standards.
4. Adjudication method for the test set
This concept is not applicable as the "test set" involves objective performance testing against established standards, not subjective expert reviews or diagnostic interpretations.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
This concept is not applicable as the device is a medical glove, not an AI-assisted diagnostic tool requiring human reader studies.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
This concept is not applicable as the device is a medical glove, not an AI algorithm. Its performance is inherent to its physical and chemical properties.
7. The type of ground truth used
The "ground truth" for the performance claims of these gloves is based on standardized laboratory test results defined by the relevant ASTM (American Society for Testing and Materials) and ISO (International Organization for Standardization) standards. These include:
- Physical measurements (e.g., length, width, thickness).
- Mechanical properties (e.g., tensile strength, elongation).
- Barrier integrity (e.g., freedom from holes).
- Chemical resistance (e.g., breakthrough time for drugs).
- Biocompatibility (e.g., irritation, sensitization, cytotoxicity, systemic toxicity).
8. The sample size for the training set
This concept is not applicable as the device is a medical glove, not a machine learning model that requires a training set.
9. How the ground truth for the training set was established
This concept is not applicable as the device is a medical glove, not a machine learning model.
Ask a specific question about this device
Page 1 of 1